The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

New weight loss drugs like Ozempic and Wegovy help suppress appetite, leading to significant weight loss, but they come with ...

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Rosie O'Donnell said she’s lost more weight since taking Mounjaro for her diabetes, admitting that she feels healthier and her new clothing size is “shocking.” ...

Only Zepbound is FDA-approved for weight loss. Compared to GLP-1 drugs or Ozempic ... her office will teach the patient how to inject it the first time, and the patient can do it themselves ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug more accessible for some patients.

The average retail price for Zepbound is nearly $1,300 ... transition period for people taking compounded weight-loss medications to give them time to prepare for such as change, said CEO Scott ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...